share_log

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $6

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $6

HC Wainwright & Co.维持Co-Diagnostics的买入,将目标价下调至6美元
Benzinga Real-time News ·  2022/11/14 06:28

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $9 to $6.

HC Wainwright & Co. 分析师陈毅维持Co-Diagnostics(纳斯达克股票代码:CODX)的买入,并将目标股价从9美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发